Alnera Aluminium
301613
Tibet Duo Rui Pharmaceutical
301075
ChengDu Sheng Nuo Biotec
688117
4
THEC
833509
5
Shenzhen Jasic Technology
300193
US Stock MarketDetailed Quotes
MAPS WM Technology
- 1.210
- -0.030-2.42%
Close Mar 28 16:00 ET
- 1.210
- 0.0000.00%
Post 20:01 ET
127.08MMarket Cap15.13P/E (TTM)
1.230High1.195Low351.07KVolume1.230Open1.240Pre Close425.60KTurnover2.92%Turnover Ratio15.13P/E (Static)105.03MShares1.65052wk High3.53P/B14.53MFloat Cap0.70052wk Low--Dividend TTM12.01MShs Float29.500Historical High--Div YieldTTM2.82%Amplitude0.596Historical Low1.212Avg Price1Lot Size
WM Technology Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.85%184.51M | 2.59%47.67M | -0.29%46.55M | -5.20%45.9M | -4.37%44.39M | -12.78%187.99M | -5.72%46.47M | -7.55%46.69M | -16.93%48.42M | -19.21%46.42M |
| Operating revenue | -1.85%184.51M | 2.59%47.67M | -0.29%46.55M | -5.20%45.9M | -4.37%44.39M | -12.78%187.99M | -5.72%46.47M | -7.55%46.69M | -16.93%48.42M | -19.21%46.42M |
| Cost of revenue | -28.00%9.02M | -17.60%2.29M | -27.63%2.18M | -30.69%2.25M | -34.12%2.3M | -18.69%12.53M | -21.43%2.78M | -29.42%3.02M | -16.04%3.24M | -6.58%3.49M |
| Gross profit | 0.02%175.5M | 3.87%45.38M | 1.60%44.37M | -3.38%43.66M | -1.95%42.09M | -12.32%175.47M | -4.50%43.69M | -5.53%43.67M | -17.00%45.18M | -20.09%42.92M |
| Operating expense | -5.18%160.75M | 1.53%40.83M | -4.09%39.17M | 2.48%42.43M | -18.58%38.33M | -36.13%169.52M | -37.30%40.21M | -38.00%40.84M | -38.62%41.4M | -30.75%47.07M |
| Selling and administrative expenses | -8.52%111.04M | -0.87%29.12M | -11.89%26.17M | 0.86%29.6M | -20.65%26.16M | -40.32%121.39M | -40.50%29.38M | -42.20%29.7M | -43.27%29.35M | -35.27%32.97M |
| -Selling and marketing expense | -14.12%40.42M | -7.82%10.05M | -16.22%9.67M | -11.92%11.07M | -20.12%9.63M | -43.03%47.07M | -47.43%10.9M | -35.44%11.54M | -43.19%12.57M | -44.89%12.06M |
| -General and administrative expense | -4.97%70.62M | 3.23%19.07M | -9.13%16.49M | 10.43%18.53M | -20.96%16.53M | -38.48%74.31M | -35.48%18.47M | -45.80%18.15M | -43.33%16.78M | -28.04%20.91M |
| Research and development costs | 1.18%36.43M | -0.59%8.07M | 22.41%9.48M | 4.80%9.64M | -15.59%9.23M | -28.74%36M | -33.34%8.12M | -35.37%7.75M | -30.63%9.2M | -16.47%10.93M |
| Depreciation amortization depletion | 9.44%13.28M | 33.91%3.64M | 3.59%3.52M | 11.63%3.19M | -7.26%2.94M | 5.52%12.13M | 5.19%2.72M | 35.10%3.4M | 16.15%2.86M | -19.72%3.17M |
| -Depreciation and amortization | 9.44%13.28M | 33.91%3.64M | 3.59%3.52M | 11.63%3.19M | -7.26%2.94M | 5.52%12.13M | 5.19%2.72M | 35.10%3.4M | 16.15%2.86M | -19.72%3.17M |
| Operating profit | 148.03%14.75M | 30.92%4.55M | 83.63%5.2M | -67.46%1.23M | 190.67%3.76M | 109.10%5.95M | 118.92%3.48M | 114.43%2.83M | 129.06%3.78M | 70.91%-4.15M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | 88.35%-2.52M | 94.10%-862K | 102.53%135K | 100.28%5K | -1,101.68%-1.79M | -113.34%-21.58M | -110.27%-14.61M | -181.74%-5.35M | -105.70%-1.8M | 100.96%179K |
| Gain on sale of security | ---- | ---- | 227.17%585K | 144.02%460K | -217.24%-850K | -94.07%1.51M | -52.05%2.29M | -106.98%-460K | -103.24%-1.05M | 103.98%725K |
| Special income (charges) | --0 | --0 | --0 | ---- | ---- | -465.28%-24.4M | ---16.02M | ---8.38M | ---- | ---- |
| -Less:Impairment of capital assets | --0 | --0 | --0 | ---- | ---- | 465.28%24.4M | --16.02M | --8.38M | ---- | ---- |
| Other non- operating income (expenses) | -290.82%-2.52M | 23.95%-667K | -112.87%-450K | 39.74%-455K | -72.71%-943K | -99.06%1.32M | -100.62%-877K | 7,092.00%3.5M | -11.36%-755K | -8.76%-546K |
| Income before tax | 178.25%12.23M | 133.14%3.69M | 312.54%5.34M | -37.67%1.24M | 149.58%1.97M | -116.21%-15.63M | -108.98%-11.14M | 80.83%-2.51M | -89.30%1.98M | 87.97%-3.97M |
| Income tax | -50.54%46K | -127.96%-26K | 21K | 42K | 9K | -99.95%93K | -99.95%93K | 0 | 0 | 0 |
| Net income | 177.49%12.19M | 133.09%3.72M | 311.70%5.32M | -39.79%1.19M | 149.36%1.96M | 80.97%-15.73M | 81.53%-11.23M | 75.99%-2.51M | -90.01%1.98M | 87.29%-3.97M |
| Net income continuous Operations | 177.49%12.19M | 133.09%3.72M | 311.70%5.32M | -39.79%1.19M | 149.36%1.96M | 80.97%-15.73M | 81.53%-11.23M | 75.99%-2.51M | -90.01%1.98M | 87.29%-3.97M |
| Minority interest income | 178.02%4.55M | 133.15%1.37M | 303.90%1.99M | -36.86%478K | 148.13%719K | -117.48%-5.83M | -108.61%-4.12M | 81.62%-974K | -90.72%757K | 91.38%-1.49M |
| Net income attributable to the parent company | 177.18%7.64M | 133.06%2.35M | 316.64%3.33M | -41.60%716K | 150.10%1.24M | 91.47%-9.9M | 93.45%-7.11M | 70.22%-1.54M | -89.51%1.23M | 82.19%-2.48M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 177.18%7.64M | 133.06%2.35M | 316.64%3.33M | -41.60%716K | 150.10%1.24M | 91.47%-9.9M | 93.45%-7.11M | 70.22%-1.54M | -89.51%1.23M | 82.19%-2.48M |
| Basic earnings per share | 172.73%0.08 | 125.00%0.02 | 250.00%0.03 | 0.00%0.01 | 133.33%0.01 | 91.91%-0.11 | 93.28%-0.08 | 66.67%-0.02 | -92.86%0.01 | 84.21%-0.03 |
| Diluted earnings per share | 172.73%0.08 | 125.00%0.02 | 250.00%0.03 | 0.00%0.01 | 133.33%0.01 | 91.91%-0.11 | 93.28%-0.08 | 66.67%-0.02 | -92.31%0.01 | 84.21%-0.03 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings